Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial

Nature Medicine 2026 Open access

Read full text
Authors: Stephen J. Nicholls, Adam J. Nelson, Marc Ditmarsch, John J.P. Kastelein, Christie M. Ballantyne, Kausik K. Ray, Ann Marie Navar, Steven E. Nissen, Anne C. Goldberg, Liam R. Brunham, Erin Wuerdeman, Annie L. Neild
+11 more Douglas Kling, Andrew Hsieh, Julie Butters, Brian A. Ference, ULRICH LAUFS, Maciej Banach, Roxana Mehran, Alberico L. Catapano, MICHAEL SZAREK, Violeta Balinskaite, Michael H. Davidson
DOI: 10.1038/s41591-025-04179-4
Cited by: 8
References: 38

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Lipid metabolism and disorders Cholesterol and Lipid Metabolism

Publication details

Journal / source
Nature Medicine
Publisher
Springer Science and Business Media LLC
Volume
32
Issue
3
Pages
1052–1060
Publication date
27 February 2026
Language
EN